ABSTRACT: Traumatic knee injuries often result in damage to articular cartilage and other joint structures. Such trauma is a strong risk factor for the future development and progression of osteoarthritis (OA). The molecular mechanisms and signaling pathways modulating response to knee joint trauma remain unclear. Moreover, investigations of biomarkers influencing responses have been targeted rather than broad, unbiased discovery studies. Herein, we characterize the complete complement of extracellular RNA (exRNA) in the synovial fluid of 14 subjects following knee injury. Fluid was collected during surgery from the injured knees, and from the contralateral knee in a subset, undergoing surgical repair of the ACL and/or meniscal repair/debridement. Arthroscopic grading of chondral damage in four knee compartments was performed using the Outerbridge classification. exRNA was extracted and subjected to massively parallel total RNA sequencing. Differential abundance of RNA was calculated between the subject cohorts of injured and non-injured knee, average Outerbridge score !0.5 and less, and chronic and acute injury duration defined as 4 months till surgery or longer. Overall, expression of several thousand genes was identified in the synovial fluid. Furthermore, differential expression analysis suggests a role of exRNA fragments of matrix metalloproteinases and skeletal muscle fiber genes in the response to traumatic injury. Together, these data suggest that high-throughput approaches can indicate exRNA molecular signatures following knee trauma. Future studies are required to more fully characterize the biological roles of these exRNA and the cadence of their respective release that may lead to translational treatment options for post-traumatic OA. ß
Osteoarthritis (OA) is the most common chronic joint disease and the leading cause of disability of individuals over the age of 60 1,2 which represents a significant health concern as joint replacement surgeries are expected to increase by more than 600% over the next 15 years. 3 The strongest risk factor for OA is traumatic joint injury. In the case of the knee, more than 50% of anterior cruciate ligament (ACL) and/or meniscus injury patients eventually develop OA [4] [5] [6] and the degree and progression of disease is accelerated in these cases. 7 The inciting trauma is argued by some to be the initial event in the development of posttraumatic OA (PTOA). 8 Even after anatomical reconstruction and rehabilitation, the risk for subsequent post-traumatic OA remains high, 8 suggesting that alternative approaches are needed to mitigate the risk for this burdensome problem.
The molecular changes following joint trauma affect not just a single tissue, but rather chondrocytes, synoviocytes, osteoblasts, as well as other tissues that synthesize and secrete pro-inflammation cytokines, and cartilage-degrading enzymes. 9, 10 Attempts to characterize these factors have been made with several studies revealing protein molecules and cytokine contributions in response to traumatic joint injury. [12] [13] [14] [15] Beyond these characterized protein based biomarkers, recent research has indicated that extracellular RNA (exRNA) plays a critical role in physiological stress responses in complex local cell-cell communication and as a circulating factor in plasma to influence distant effects. 11 Intracellularly, RNA performs many functions including coding from proteins, regulating gene expression, altering chromatin conformations, and acting enzymatically. Recently, RNA has been detected outside of cells in numerous bodily fluids including plasma, urine, cerebrospinal fluid, and others and is believed to act as a signaling molecule. 12 These extracellular RNA molecules are likely contained in membrane enclosed micro-vesicles, such as exosomes, or tightly associated with proteins and/or lipids for protection in the extracellular environment. 11 These exRNA have been studied in a range of fluids utilizing high throughput genomic technologies to identify several species of RNA including rRNA, tRNA, miRNA, and mRNA. 13 While the mechanisms of creation, delivery, and effects are still areas of investigation, specific exRNA molecules have been found to be biomarkers for surveying and monitoring diverse conditions including brain cancers, 14 cardiovascular disease, 15 and multiple sclerosis. 16 In the context of knee trauma, it has been demonstrated that synovial exRNA can modulate inflammatory processes. 17 The presence of exRNA in synovial fluid of arthritis patients has been noted 17 and targeted analysis of pre-defined RNA molecules have been performed for specific miRNAs or protein coding genes. [18] [19] [20] However, global characterization of exRNA in synovial fluid has yet to be fully understood, though recently, our group identified exRNA fragments of OA related genes differentially present based on time after a meniscal tear. 21 Presently, we have built upon our previous work and implemented a high throughput, massively parallel synovial exRNA sequencing method to isolate, identify, quantify, and differentiate exRNA present in the synovial fluid of knee trauma subjects. This was performed in a cohort of 14 individuals undergoing ACL and/or meniscal repair surgery, including five with a sample from the uninjured contralateral knee. This cohort offers the opportunity for a proof of principle study to determine exRNA differences arising following trauma, chondral integrity, and time to intervention surgery. We hypothesize that traumatic knee injuries will induce specific changes in exRNA influencing structural, inflammatory, and/or catabolic processes that may contribute to the initiation and progression of PTOA.
MATERIALS AND METHODS

Patient Sample Acquisition
This is a retrospective cohort study with level 3 clinical evidence approved by the University of Miami Institutional Review Board (IRB) under protocol 20100506 and all patients signed informed consent. All subjects had undergone a meniscectomy and/or ACL reconstruction surgery at the UHealth Sports Medicine Institute, University of Miami, Miller School of Medicine. Inclusion criteria included; participants between the ages of 15 and 50 and a confirmed history of torn ACL and/or medial/lateral meniscus. All standard-ofcare procedures related to the surgical treatment of the torn meniscus and/or ACL including all standard pre-surgical tests, surgery, and postsurgical rehabilitation were performed. Participants were excluded if they were younger than 15 years of age, had prior knee or ligament surgeries to the affected knee, a BMI >30, had rheumatoid arthritis, neuromuscular disease, and/or diabetes, or had a steroid injection within 3 months of surgery. Fourteen individuals (Table 1 ) met inclusion and synovial fluid was collected at the time of surgery under anesthesia through an inferior lateral approach adjacent to the patella following insertion of a loaded cannula for arthroscopic procedures. Aspirated fluid was stored in RNAase free 2 ml tubes kept on wet ice.
Synovial Extracellular RNA Extraction
Synovial fluid was aspirated prior to surgical management within the sterile operative field. Immediately following aspiration, synovial fluid samples were transferred to the John P. Hussman Institute for Genomics for processing. First, 1 ml of fluid was centrifuged at 8,000g for 5 min to pellet any cells or cell debris and the supernatant was stored at À80˚C. Then, extracellular RNA was extracted using a modified protocol of the Qiagen miRNeasy Mini Kit (Qiagen, Germantown, MD). Briefly, 1.5 ml of synovial fluid was incubated for 5 min with Qiazol reagent (Qiagen, Germantown, MD) followed by addition of 1 ml of chloroform and vigorous agitation for 2 min. Aliquots of the solution were centrifuged for 14,000 rpm for 20 min at 4˚C and the aqueous layer recovered. The aqueous layer of all aliquots were passed through the miRNeasy columns sequentially and washed per manufacturer's instructions. The final product was eluted in 40 ml of RNase free water and stored at À80˚C.
exRNA Sequencing RNA was quantified by Qubit RNA assay (Invitrogen Life Technologies, Carlsbad, CA) and qualified by Agilent 2100 RNA 6000 Pico Chip (Agilent Technologies, Santa Clara, CA). Sequencing library preparation was performed using 1 ng of RNA and the SMARTer smRNA-Seq Kit for Illumina (Takara, Shiga, Japan) according to manufacturer's protocols. This 
Sequence Analysis
The RNAseq data were processed through a bioinformatics pipeline consisting of read quality control with FASTQC software, 22 read trimming using cutadapt, 23 and alignment to the human reference genome using the Small RNA-seq single-end pipeline from ENCODE using the STAR aligner. 24 Uniquely mapping reads were quantified using the STAR GeneCounts function against the human GENCODE version 19 gene set.
Statistical Analysis
Gene count normalization and differential abundance calculations were performed using the edgeR software. 25 All differential abundance calculations were performed within edgeR with the generalized linear model (GLM) function using sex as a covariate. Due to sample size constraints, for comparisons based on Outerbridge score and injury duration, a t-test was performed on the means of BMI and age and found to not be significantly different between comparison groups and therefore were not included in the GLM. Differential expression was determined at a threshold of p 0.001 and fold change (FC) !1.5. The plotMDS function in R was used to create multidimensional scaling plots by calculating the distance between samples by Euclidean distance for the all genes and plotting these in two dimensions. Gene ontology enrichment analysis was performed using Ingenuity Pathway Analysis (QIAGEN, Germantown, MD).
RESULTS
exRNA Sequencing exRNA extraction yield was variable with 2 ml of synovial fluid resulting in 1-10 ng of RNA as quantified by Qubit analysis. Isolated synovial exRNA size was small ranging from 15 to 150 bp with a peak of around 40 bp according to Agilent Bioanalyzer traces (Fig. 1) . This size was reflected in the sequencing reads, following trimming of adapters, of 15-45 bp with more than 70% of the reads less than 20bp.
Overall mapping rates to the human genome were 65.8-78.5% with uniquely aligning reads at 10.3-24.6%. The uniquely aligned reads represented more than 10,000 RNA molecules with evidence of expression, defined as at least 10 reads mapping to that feature in at least one individual including rRNA, miRNA, and protein coding fragments. This indicates a wide diversity of exRNA molecules present in the synovial fluid (Fig. 2) .
exRNA in Injured Versus Contralateral Knees
For five subjects, differential abundance of exRNA between paired injured and contralateral knees was determined to identify molecules modulated specifically by the injury process. Multidimensional scaling analysis of total RNA expression suggested separation of samples based on their injury status (Fig. 3A) . A total of 69 protein coding genes (44 increased, 25 decreased in injured knees) and eight miRNA (three increased, five decreased) were observed with nominally significant differences (p 0.001, FC ! 1.5) (Fig. 3B, Table S-1) . The protein coding genes indicated enrichment of matrix metallopeptidases by Ingenuity Pathway Analysis including increases in three matrix metallopeptidase (MMP3, MMP21, and MMP1) and MIR320a; all of which have been previously implicated in tissue and cartilage damage responses.
exRNA Based on Average Outerbridge Score The cohort was divided into similar sized groups at the median average Outerbridge score (0.5) with eight individuals with average intraoperative Outerbridge scores across four knee components greater than 0.5 and six subjects with a lesser average score. Multidimensional scaling showed some distinct clustering of individuals based on their average Outerbridge score (Fig.  3C ). Comparing exRNA abundances between these groups revealed 278 protein coding genes (87 increased, 191 decreased in higher average score individuals) and seven miRNA (five increased, two decreased) with significant differential expression (p 0.001, FC ! 1.5) (Fig. 3D , Table S-2) . Ingenuity Pathway Analysis of protein coding genes demonstrated strong enrichment of decreased translational initiation factors (EIF1, EIF2S1, and EIF3E ÀI, and ÀL) in subjects with higher Outerbridge scores. Specific analysis of genes thought to be involved in chondral pathogenesis indicated an increase in a matrix metallopeptidase (ADAM12). Among the five miRNAs increased in high average scores were three with previous evidence to regulate cartilage formation and function (MIR199B and MIR4484).
exRNA Based on Duration of Injury Our previous work suggested a distinct exRNA profile based on injury duration more or less than four months. 21 Nine subjects had acute injuries (less than 4 months between injury and surgery) and five chronic injuries (more than 4 months). Multidimensional scaling suggested some but incomplete separation of samples based on injury duration (Fig. 3E) . A total of 46 protein coding genes (33 increased, 13 decreased in longer duration individuals) and a single decreased miRNA were identified with significant differential expression (p 0.001, FC ! 1.5) (Fig. 3F, Table S-3) . Enrichment was seen in calcium signaling from muscle fibers. This included increases in skeletal muscle troponin C2 and I2 (TNNC2 and TNNI2) tropomyosin 2 (TPM2), myosin light chain 1 (MYL1), and skeletal muscle actin (ACTA1).
DISCUSSION
The identification and characterization of human exRNA is broadly applicable across a wide range of physiological conditions. How these processes are related to PTOA and which specific molecules control this effect are not understood. Attempts to elucidate these exRNA signals in the synovial fluid that may modulate the OA cascade have generally centered on in vitro cell culture 26 or in vivo analyses of a limited number of specific candidate miRNAs. 20, 27 Our previous study into an unbiased RNA sequencing study of dynamic synovial exRNA 21 queried all possible exRNA in the synovial fluid, but included a small number of subjects and did not take into account the degree of chondral damage for each patient. Moreover, there was no analysis of control knees. The current study builds on the techniques presented there while enhancing power for detection of exRNA signatures of trauma and other clinical variables. Herein, the sample size is doubled, contralateral knees have been collected and compared, and the degree of chondral damage was assessed intraoperatively.
To our knowledge, the present study is one of the first to differentiate exRNA profiles between injured and contralateral knees. When examining differences between these samples types in our unique dataset, the most evident group of protein coding genes with enriched molecules in injured knees were matrix metallopeptidases (MMPs), specifically MMP3, MMP21, and MMP1. Previous studies have implicated these molecules in cartilage degradation. MMP3 in particular has been identified as increased in tissue of OA patients particularly in early stages. 28 Furthermore, MMP protein levels are increased in the synovial fluid of injured joints 29 and this increase has been linked to inflammation and early onset of OA. 30 Similarly, the increase in MIR320A has been noted in injured bones 31 and is thought to regulate osteocyte differentiation. 32 The identification of exRNA corresponding to these known modulators of bone and cartilage function may indicate targets for future therapeutic intervention.
Beyond injured versus control comparisons, we attempted to define subsets in our cohort based on clinical characteristics. First, by assessing the degree of chondral damage intra-operatively, an average Outerbridge score was calculated. The exRNA of subjects with higher average damage shows a strong decrease in translation initiation factors. This may be representative of endoplasmic reticulum stress in the joint cells induced by inflammation. 33 In addition, levels of exRNA fragments of ADAM12 are increased with more average chondral damage in this dataset and this gene has been previously identified as the only ADAM family gene to be overexpressed in cartilage tissue of OA patients. 34 Similarly, dividing by injury duration reveals a potential role for exRNA of skeletal calcium signaling genes. Troponins are calcium binding molecules critical for skeletal muscle contraction. Overexpression and abundance of these genes have been noted in muscle damage 35 and also in soft tissue injuries. 36 There remain some limitations with the current study. The specific biological function of extracellular fragments of these protein coding and miRNA genes is not yet known. While categorizing these genes implicates differentiation and function of bone, muscle, and cartilage as well as catabolism of extracellular matrix and collagen, there are several additional steps that are necessary to begin to unravel the role of these molecules. First, continuing to increase sample numbers and careful control of clinical parameters including injury type, time to surgery, and comprehensive clinical data, such as MRI availability, will strengthen the universality of these findings. For example, inflammation has been linked to alterations of exRNA, 37, 38 therefore investigation of cohorts of individuals with varying degrees of synovitis may be revealing. Similarly, injury specific factors such as bone bruising or degree of damage (e.g., torn vs. intact meniscus) could be enlightening. For example, in a targeted study of extracellular miRNAs, degenerative meniscal tears have a distinct profile compared to traumatic. 18 A second step to build upon this study is determining if these biomarkers exist as circulating factors that might induce endocrine effects. This is critical as this correlation may help clinicians use applicable modalities to monitor the progression and increase our understanding of these genes. Therefore, screening of the plasma exRNA in these individuals may find correlative relationships which would yield another way to evaluate individuals for these destructive processes. Third, methodological advancements to detect correlation and association of exRNA profiles to continuous factors (such as BMI, age, activity levels, etc) [39] [40] [41] will allow for more powerful statistical analyses of these data. Fourth, in vitro characterization of these molecules and delivery in cell culture and animal models will enlighten the specific functions of these molecules be they gene silencing, expression promoting, or otherwise. Finally, expansion of these findings into other joints and injuries will determine whether this mechanism is a generalized physiological mechanism.
Overall, there is an unmet clinical need for studies determining the etiology and therefore potential novel treatment approaches in patients with knee trauma to mitigate future progression of OA. Despite remaining questions outlined above, this study demonstrates that exRNA molecules can be isolated, sequenced, and characterized from synovial fluid in an unbiased and high throughput manner. Our results indicate that exRNA can be specifically modulated based on clinical features including injury or contralateral, Outerbridge scores, and time to surgery. These exRNA include pathways previously implicated in bone and cartilage maintenance and degradation pathways including matrix metalloproteinases and several regulatory miRNAs. While the mechanism of these exRNAs remains to be elucidated, expansion of this study may reveal specific molecules altered by these conditions that may be used as biomarkers.
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